T1	Participants 897 928	14 communities in matched pairs
T2	Participants 930 1145	People aged 5 years or older in seven communities received randomly assigned diethylcarbamazine 6 mg/kg and people in the other seven communities received diethylcarbamazine 6 mg/kg plus ivermectin 400 micrograms/kg
T3	Participants 1584 1639	2219 (87.6%) of 2534 eligible people received treatment
T4	Participants 763 832	area of Papua New Guinea endemic for intense W bancrofti transmission
